Skip to main content

Bridgefront Capital, LLC

SEC CIK
0001725690
Latest filing
Aug 14, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Bridgefront Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q2 2024
Holdings of VRDN by Bridgefront Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−21,366−100.0%Sold outHolders
Q4 202521,366$664.9K0.2%+21,366NewHolders
Q3 20240$00.0%−15,709−100.0%Sold outHolders
Q2 202415,709$204.4K0.1%+15,709NewHolders